Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. Keeping that in mind, here are two profitable companies that balance growth and profitability and one that may struggle to keep up.

One Stock to Sell:

Collegium Pharmaceutical (COLL)

Trailing 12-Month GAAP Operating Margin: 23%

Pioneering abuse-deterrent technology in a field plagued by addiction concerns, Collegium Pharmaceutical (NASDAQ: COLL) develops and markets specialty medications for treating moderate to severe pain, including abuse-deterrent opioid formulations.

Why Are We Hesitant About COLL?

1. Modest revenue base of $780.6 million gives it less fixed cost leverage and fewer distribution channels than larger companies
2. Day-to-day expenses have swelled relative to revenue over the last two years as its adjusted operating margin fell by 4.8 percentage points
3. Diminishing returns on capital suggest its earlier profit pools are drying up

Collegium Pharmaceutical is trading at $33.24 per share, or 4.5x forward P/E. Read our free research report to see why you should think twice about including COLL in your portfolio.

Two Stocks to Watch:

Molina Healthcare (MOH)

Trailing 12-Month GAAP Operating Margin: 1.7%

Founded in 1980 as a provider for underserved communities in Southern California, Molina Healthcare (NYSE: MOH) provides managed healthcare services primarily to low-income individuals through Medicaid, Medicare, and Marketplace insurance programs across 21 states.

Why Could MOH Be a Winner?

1. Annual revenue growth of 18.7% over the last five years was superb and indicates its market share increased during this cycle
2. Sizeable revenue base of $45.43 billion gives it economies of scale and favorable reimbursement terms with healthcare providers

Molina Healthcare’s stock price of $134.38 implies a valuation ratio of 23.8x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.

Moody's (MCO)

Trailing 12-Month GAAP Operating Margin: 43.4%

Founded in 1900 during America's railroad boom when investors needed reliable information on bond risks, Moody's (NYSE: MCO) provides credit ratings, risk assessment tools, and analytical solutions that help organizations evaluate financial risks and make informed investment decisions.

Why Are We Bullish on MCO?

1. Offerings and unique value proposition resonate with customers, as seen in its above-market 14.2% annual sales growth over the last two years
2. Performance over the past two years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
3. Industry-leading 63.1% return on equity demonstrates management’s skill in finding high-return investments

At $438.82 per share, Moody's trades at 26x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.